DE1252898B
(de)
|
1965-06-12 |
1967-10-26 |
Bayer Ag |
Verfahren zur Herstellung von Copolymerisaten des Trioxans
|
US5240928A
(en)
|
1989-07-03 |
1993-08-31 |
Merck & Co., Inc. |
Substituted quinazolinones as angiotensin II antagonists
|
DE3930262A1
(de)
|
1989-09-11 |
1991-03-21 |
Thomae Gmbh Dr K |
Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
KR910009330B1
(ko)
|
1989-10-23 |
1991-11-11 |
재단법인 한국화학연구소 |
항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
|
CA2037630C
(en)
|
1990-03-07 |
2001-07-03 |
Akira Morimoto |
Nitrogen-containing heterocylic compounds, their production and use
|
US5470975A
(en)
|
1990-10-16 |
1995-11-28 |
E.R. Squibb & Sons, Inc. |
Dihydropyrimidine derivatives
|
US5290780A
(en)
|
1991-01-30 |
1994-03-01 |
American Cyanamid Co. |
Angiotensin II receptor blocking 2,3,6 substituted quinazolinones
|
US5238942A
(en)
|
1991-05-10 |
1993-08-24 |
Merck & Co., Inc. |
Substituted quinazolinones bearing acidic functional groups as angiotensin ii antagonists
|
DE4121214A1
(de)
|
1991-06-27 |
1993-01-14 |
Bayer Ag |
7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
|
US5202322A
(en)
|
1991-09-25 |
1993-04-13 |
Merck & Co., Inc. |
Quinazolinone and pyridopyrimidine a-II antagonists
|
US5532243A
(en)
|
1992-02-14 |
1996-07-02 |
The Dupont Merck Pharmaceutical Company |
Antipsychotic nitrogen-containing bicyclic compounds
|
US5358951A
(en)
|
1993-04-23 |
1994-10-25 |
American Cyanamid Company |
Angiotensin II receptor blocking 2, 3, 6 substituted quinazolinones
|
DE4407047A1
(de)
|
1994-03-03 |
1995-09-07 |
Merck Patent Gmbh |
Acetamide
|
US20010016657A1
(en)
|
1997-03-18 |
2001-08-23 |
Smithkline Beecham P.L.C. |
Substituted isoquinoline derivatives and their use as anticonvulsants
|
EE200000458A
(et)
|
1998-02-04 |
2002-02-15 |
Banyu Pharmaceutical Co., Ltd. |
Tsüklilise amiini N-atsüülderivaadid
|
JP2001039950A
(ja)
|
1999-07-30 |
2001-02-13 |
Banyu Pharmaceut Co Ltd |
N−アシル環状アミン誘導体
|
CA2389034A1
(en)
|
1999-10-27 |
2001-05-03 |
Cor Therapeutics, Inc. |
Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
|
WO2002070523A1
(en)
|
2001-03-07 |
2002-09-12 |
Pfizer Products Inc. |
Modulators of chemokine receptor activity
|
EP1499306A4
(en)
|
2002-04-12 |
2007-03-28 |
Merck & Co Inc |
BICYCLIC AMIDE
|
GB0303852D0
(en)
|
2003-02-19 |
2003-03-26 |
Pfizer Ltd |
Triazole compounds useful in therapy
|
WO2005023762A1
(en)
|
2003-09-04 |
2005-03-17 |
Abbott Laboratories |
Pyrrolidine-2-carbonitrile derivatives and their use as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
|
SE0302811D0
(sv)
|
2003-10-23 |
2003-10-23 |
Astrazeneca Ab |
Novel compounds
|
GB0324790D0
(en)
|
2003-10-24 |
2003-11-26 |
Astrazeneca Ab |
Amide derivatives
|
US7226951B2
(en)
|
2003-12-17 |
2007-06-05 |
Allergan, Inc. |
Compounds having selective cytochrome P450RAI-1 or selective cytochrome P450RAI-2 inhibitory activity and methods of obtaining the same
|
KR100610731B1
(ko)
|
2004-02-24 |
2006-08-09 |
한국과학기술연구원 |
T-형 칼슘 채널 차단제로서 유용한 3,4-디히드로퀴나졸린유도체 및 그의 제조 방법
|
AU2005219438B2
(en)
|
2004-03-03 |
2011-02-17 |
Chemocentryx, Inc. |
Bicyclic and bridged nitrogen heterocycles
|
CA2569910A1
(en)
|
2004-06-09 |
2005-12-22 |
Eun Kyung Lee |
Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds
|
CN101035773B
(zh)
|
2004-08-10 |
2012-06-06 |
詹森药业有限公司 |
抑制hiv的1,2,4-三嗪-6-酮衍生物
|
US7410949B2
(en)
|
2005-01-18 |
2008-08-12 |
Hoffmann-La Roche Inc. |
Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
|
GB0504019D0
(en)
|
2005-02-26 |
2005-04-06 |
Astrazeneca Ab |
Amide derivatives
|
BRPI0610433A2
(pt)
|
2005-04-28 |
2010-11-23 |
Wyeth Corp |
forma polimórfica ii de tanaproget, processos para preparar a mesma, e para preparar forma micronizada de um composto, composição farmacêutica, método de preparação de uma composição farmacêutica, e, uso da forma polimórfica ii de tanaproget ou da forma micronizada
|
US7737279B2
(en)
|
2005-05-10 |
2010-06-15 |
Bristol-Myers Squibb Company |
1,6-dihydro-1,3,5,6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same
|
TW200800999A
(en)
|
2005-09-06 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
DK1942108T3
(da)
|
2005-10-28 |
2013-12-09 |
Ono Pharmaceutical Co |
Forbindelse indeholdende basisk gruppe samt anvendelse deraf
|
PL1961744T3
(pl)
|
2005-11-18 |
2013-09-30 |
Ono Pharmaceutical Co |
Związek zawierający grupę zasadową oraz jego zastosowanie
|
JP2007176809A
(ja)
|
2005-12-27 |
2007-07-12 |
Hideaki Natsukari |
複素環置換アミド化合物、その製造法および医薬組成物
|
WO2007103719A2
(en)
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
JP2008031064A
(ja)
|
2006-07-27 |
2008-02-14 |
Astellas Pharma Inc |
ジアシルピペラジン誘導体
|
EP2069315B1
(en)
|
2006-09-11 |
2011-09-07 |
N.V. Organon |
Quinazolinone and isoquinolinone acetamide derivatives
|
US7638526B2
(en)
|
2006-09-15 |
2009-12-29 |
Schering Corporation |
Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism
|
US8735411B2
(en)
|
2006-10-02 |
2014-05-27 |
Abbvie Inc. |
Macrocyclic benzofused pyrimidine derivatives
|
TWI405763B
(zh)
|
2006-11-02 |
2013-08-21 |
Targacept Inc |
菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
|
WO2008059026A1
(en)
|
2006-11-15 |
2008-05-22 |
High Point Pharmaceuticals, Llc |
Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes
|
TW200831085A
(en)
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
EP1975165A1
(de)
|
2007-03-27 |
2008-10-01 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Substituierte Pyrrolidinamide, deren Herstellung und deren Verwendung als Arzneimittel
|
BRPI0809617A2
(pt)
|
2007-03-29 |
2014-09-16 |
Hoffmann La Roche |
Inibidores não-nucleosídicos da transcriptase reversa
|
CL2008001002A1
(es)
|
2007-04-11 |
2008-10-17 |
Actelion Pharmaceuticals Ltd |
Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
|
JP2010524987A
(ja)
|
2007-04-27 |
2010-07-22 |
サノフィ−アベンティス |
2−ヘテロアリール−ピロロ[3,4−c]ピロール誘導体及びscd阻害剤としてのそれらの使用
|
UA99626C2
(ru)
|
2007-08-07 |
2012-09-10 |
Эбботт Гмбх Унд Ко. Кг |
Соединения хинолина, пригодные для лечения нарушений, реагирующих на модуляцию рецептора 5-нт6 серотонина
|
DE102007047737A1
(de)
|
2007-10-05 |
2009-04-30 |
Merck Patent Gmbh |
Piperidin- und Piperazinderivate
|
EP3797775A1
(en)
|
2007-10-19 |
2021-03-31 |
Novartis AG |
Compositions and methods for treatment of diabetic retinopathy
|
AR069126A1
(es)
|
2007-10-31 |
2009-12-30 |
Janssen Pharmaceutica Nv |
Diaminas en puente o fusionadas sustituidas con arilo como moduladores de leucotrieno a4 hidrolasa
|
JP2009161449A
(ja)
|
2007-12-28 |
2009-07-23 |
Lion Corp |
Ppar活性促進剤並びに美容用飲食品、皮膚外用剤及び医薬
|
AU2009261248A1
(en)
|
2008-06-19 |
2009-12-23 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
US8673917B2
(en)
|
2008-09-09 |
2014-03-18 |
Sanofi |
2-heteroaryl-pyrrolo [3,4-C]pyrrole derivatives, and use thereof as SCD inhibitors
|
TW201020247A
(en)
|
2008-11-06 |
2010-06-01 |
Gruenenthal Gmbh |
Substituierte disulfonamide
|
EP2358677B1
(en)
|
2008-11-17 |
2014-01-08 |
F. Hoffmann-La Roche AG |
Naphthylacetic acids used as crth2 antagonists or partial agonists
|
DE102008059578A1
(de)
|
2008-11-28 |
2010-06-10 |
Merck Patent Gmbh |
Benzo-Naphtyridin Verbindungen
|
BRPI0922154A2
(pt)
|
2008-12-01 |
2016-01-05 |
Merck Patent Gmbh |
pirido[4,3-d]pirimidinas 2,5-diamino-substituídas como inibidores de autotaxina contra o cãncer
|
TW201035102A
(en)
|
2009-03-04 |
2010-10-01 |
Gruenethal Gmbh |
Sulfonylated tetrahydroazolopyrazines and their use as medicinal products
|
AU2010219705A1
(en)
|
2009-03-05 |
2011-07-21 |
Daiichi Sankyo Company, Limited |
Pyridine derivative
|
WO2010108268A1
(en)
|
2009-03-23 |
2010-09-30 |
Merck Frosst Canada Ltd. |
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
TW201038572A
(en)
|
2009-03-25 |
2010-11-01 |
Gruenenthal Gmbh |
Substituted spiro-amide compounds
|
JP5779172B2
(ja)
*
|
2009-04-02 |
2015-09-16 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
オートタキシン阻害剤
|
EP2623101B1
(en)
|
2009-04-02 |
2021-04-21 |
Merck Patent GmbH |
Piperidine and piperazine derivatives as autotaxin inhibitors
|
KR20120027192A
(ko)
|
2009-04-02 |
2012-03-21 |
메르크 파텐트 게엠베하 |
오토탁신 저해제로서의 헤테로시클릭 화합물
|
FR2945534B1
(fr)
|
2009-05-12 |
2012-11-16 |
Sanofi Aventis |
DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
|
MX2011012345A
(es)
|
2009-05-22 |
2012-01-31 |
Exelixis Inc |
Inhibidores de pi3k/mtor basados en benzoxazepinas contra enfermedades proliferativas.
|
WO2010141817A1
(en)
|
2009-06-05 |
2010-12-09 |
Janssen Pharmaceutica Nv |
Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
|
DE102009033392A1
(de)
|
2009-07-16 |
2011-01-20 |
Merck Patent Gmbh |
Heterocyclische Verbindungen als Autotaxin-Inhibitoren II
|
JP2013501064A
(ja)
|
2009-08-04 |
2013-01-10 |
アミラ ファーマシューティカルス,インコーポレーテッド |
リゾホスファチジン酸受容体アンタゴニストとしての化合物
|
UA107360C2
(en)
|
2009-08-05 |
2014-12-25 |
Biogen Idec Inc |
Bicyclic aryl sphingosine 1-phosphate analogs
|
AR079022A1
(es)
|
2009-11-02 |
2011-12-21 |
Sanofi Aventis |
Derivados de acido carboxilico ciclico sustituidos con acilamino, su uso como productos farmaceuticos, composicion farmaceutica y metodo de preparacion
|
US8835427B2
(en)
|
2010-01-07 |
2014-09-16 |
E I Du Pont De Nemours And Company |
Fungicidal heterocyclic compounds
|
WO2011115813A1
(en)
|
2010-03-18 |
2011-09-22 |
Abbott Laboratories |
Lactam acetamides as calcium channel blockers
|
RU2524341C2
(ru)
|
2010-03-19 |
2014-07-27 |
Пфайзер Инк. |
Производные 2,3-дигидро-1н-инден-1-ил-2,7-диазаспиро[3.5]нонана и их применение в качестве антагонистов или обратных агонистов грелинового рецептора
|
CN102822171B
(zh)
|
2010-03-26 |
2015-09-02 |
默克专利有限公司 |
作为自分泌运动因子抑制剂的苯并萘啶胺类
|
GB201008005D0
(en)
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
WO2011151461A2
(en)
|
2010-06-04 |
2011-12-08 |
B.S.R.C. "Alexander Fleming" |
Autotaxin pathway modulation and uses thereof
|
JP5781071B2
(ja)
|
2010-06-29 |
2015-09-16 |
オリンパス株式会社 |
光学素子の製造方法および光学素子の製造装置
|
JP2013536200A
(ja)
|
2010-08-20 |
2013-09-19 |
アミラ ファーマシューティカルス,インコーポレーテッド |
オートタキシン阻害剤およびその使用
|
EP2611808B1
(en)
|
2010-09-02 |
2014-11-12 |
Merck Patent GmbH |
Pyrazolopyridinone derivatives as lpa receptor antagonists
|
US8999985B2
(en)
|
2010-12-02 |
2015-04-07 |
Shanghai De Novo Pharmatech Co Ltd. |
Substituted phthalazin-1(2H)-ones, preparation processes and medical uses thereof
|
CN104906103B
(zh)
|
2010-12-14 |
2018-05-18 |
电泳有限公司 |
酪蛋白激酶1δ(CK1δ)抑制剂
|
EP2714680B1
(en)
|
2011-05-27 |
2015-11-25 |
Amira Pharmaceuticals, Inc. |
Heterocyclic autotaxin inhibitors and uses thereof
|
WO2013033059A1
(en)
|
2011-08-29 |
2013-03-07 |
Bristol-Myers Squibb Company |
Spiro bicyclic diamine derivatives as hiv attachment inhibitors
|
WO2013054185A1
(en)
*
|
2011-10-13 |
2013-04-18 |
Pfizer, Inc. |
Pyrimidine and pyridine derivatives useful in therapy
|
WO2013065712A1
(ja)
|
2011-10-31 |
2013-05-10 |
東レ株式会社 |
ジアザスピロウレア誘導体及びその医薬用途
|
US8809552B2
(en)
|
2011-11-01 |
2014-08-19 |
Hoffmann-La Roche Inc. |
Azetidine compounds, compositions and methods of use
|
JP5918859B2
(ja)
|
2011-12-02 |
2016-05-18 |
フェネックス ファーマシューティカルス アーゲー |
オーファン核内受容体RARに関連するオーファン受容体−ガンマ(RORγ、NR1F3)活性の調整剤としての、慢性の炎症性疾患および自己免疫性疾患を治療するためのピロロカルボキサミド
|
TWI638802B
(zh)
|
2012-05-24 |
2018-10-21 |
芬蘭商奧利安公司 |
兒茶酚o-甲基轉移酶活性抑制化合物
|
AR091424A1
(es)
|
2012-06-13 |
2015-02-04 |
Incyte Corp |
Compuestos triciclicos sustituidos como inhibidores de receptores del factor de crecimiento del fibroplasto (fgfr)
|
PT2861566T
(pt)
|
2012-06-13 |
2017-02-08 |
Hoffmann La Roche |
Novos diazaspirocicloalcanos e azaspirocicloalcanos
|
KR20150028999A
(ko)
|
2012-06-27 |
2015-03-17 |
에프. 호프만-라 로슈 아게 |
5-아자인다졸 화합물 및 이의 사용 방법
|
EA027809B1
(ru)
|
2012-07-27 |
2017-09-29 |
Биоген Айдек Ма Инк. |
Соединения, которые являются s1p-модулирующими агентами и/или atx-модулирующими агентами
|
JP6391571B2
(ja)
|
2012-07-27 |
2018-09-19 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
Atx調節剤
|
AR092211A1
(es)
|
2012-09-24 |
2015-04-08 |
Merck Patent Ges Mit Beschränkter Haftung |
Derivados de hidropirrolopirrol
|
WO2014048881A1
(en)
|
2012-09-25 |
2014-04-03 |
Bayer Pharma Aktiengesellschaft |
Combination of regorafenib and acetylsalicylic acid for treating cancer
|
UA116547C2
(uk)
|
2012-09-25 |
2018-04-10 |
Ф. Хоффманн-Ля Рош Аг |
Біциклічні похідні
|
AR092742A1
(es)
|
2012-10-02 |
2015-04-29 |
Intermune Inc |
Piridinonas antifibroticas
|
CA2886263C
(en)
|
2012-10-25 |
2021-04-13 |
Tetra Discovery Partners, LLC |
Heteroaryl inhibitors of pde4
|
HUE030613T2
(en)
|
2012-12-31 |
2017-05-29 |
Cadila Healthcare Ltd |
Substituted phthalazin-1 (2H) -one derivatives as selective inhibitors of poly (ADP-ribose) polymerase-1
|
WO2014133112A1
(ja)
|
2013-03-01 |
2014-09-04 |
国立大学法人東京大学 |
オートタキシン阻害活性を有する8-置換イミダゾピリミジノン誘導体
|
TWI593692B
(zh)
|
2013-03-12 |
2017-08-01 |
美國禮來大藥廠 |
四氫吡咯并噻嗪化合物
|
KR20150126043A
(ko)
|
2013-03-12 |
2015-11-10 |
어큐셀라 인코포레이티드 |
안과 질환 및 장애 치료용 치환된 3-페닐프로필아민 유도체
|
AU2014231563A1
(en)
|
2013-03-12 |
2015-09-17 |
Abbvie Inc. |
Tetracyclic bromodomain inhibitors
|
AR095079A1
(es)
|
2013-03-12 |
2015-09-16 |
Hoffmann La Roche |
Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
|
US20160039825A1
(en)
|
2013-03-15 |
2016-02-11 |
Biogen Ma Inc. |
S1p and/or atx modulating agents
|
TN2016000022A1
(en)
|
2013-07-18 |
2017-07-05 |
Novartis Ag |
Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core
|
WO2015058031A1
(en)
|
2013-10-17 |
2015-04-23 |
Vertex Pharmaceuticals Incorporated |
Dna-pk inhibitors
|
BR112016010220B1
(pt)
|
2013-11-22 |
2023-05-09 |
Sabre Therapeutics Llc |
Compostos inibidores de autoxatina, composições e usos relacionados
|
AR098475A1
(es)
|
2013-11-26 |
2016-06-01 |
Bayer Cropscience Ag |
Compuestos pesticidas y usos
|
DK3074400T3
(en)
|
2013-11-26 |
2018-01-15 |
Hoffmann La Roche |
Octahydro-cyclobuta [1,2-c; 3,4-c '] dipyrrole derivatives as autotaxin inhibitors
|
UA119347C2
(uk)
|
2014-03-26 |
2019-06-10 |
Ф. Хоффманн-Ля Рош Аг |
Конденсовані [1,4]діазепінові сполуки як інгібітори продукції аутотаксину (atх) та лізофосфатидилової кислоти (lpa)
|
JO3512B1
(ar)
|
2014-03-26 |
2020-07-05 |
Astex Therapeutics Ltd |
مشتقات كينوكسالين مفيدة كمعدلات لإنزيم fgfr كيناز
|
JP2017515794A
(ja)
|
2014-03-26 |
2017-06-15 |
ビーエーエスエフ ソシエタス・ヨーロピアBasf Se |
殺菌剤としての置換[1,2,4]トリアゾール及びイミダゾール化合物
|
MA50635A
(fr)
|
2014-03-26 |
2020-08-12 |
Hoffmann La Roche |
Nouveaux composés bicycliques comme inhibiteurs de la production d'autotaxin (atx) et de l'acide lysophosphatidique
|
WO2015154023A1
(en)
|
2014-04-04 |
2015-10-08 |
X-Rx Discovery, Inc. |
Substituted spirocydic inhibitors of autotaxin
|
EP3187492A4
(en)
|
2014-08-29 |
2018-05-09 |
The University of Tokyo |
Pyrimidinone derivative having autotaxin-inhibitory activity
|
SI3207043T1
(sl)
|
2014-10-14 |
2019-04-30 |
Vitae Pharmaceuticals, Inc. |
Dihidropirolopiridinovi inhibitorji za ROR-gama
|
EA033497B1
(ru)
|
2015-02-15 |
2019-10-31 |
Hoffmann La Roche |
1-(тиофенил или фенил)сульфонил-(пирролидин)-2-карбоксамидные производные и их применение в качестве антагонистов trpa1
|
MA41898A
(fr)
|
2015-04-10 |
2018-02-13 |
Hoffmann La Roche |
Dérivés de quinazolinone bicyclique
|
CN104927727B
(zh)
|
2015-07-06 |
2017-01-11 |
香山红叶建设有限公司 |
一种玻璃幕墙用结构密封胶及其制备方法
|
PL415078A1
(pl)
|
2015-09-04 |
2017-03-13 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
|
KR20180043837A
(ko)
|
2015-09-04 |
2018-04-30 |
에프. 호프만-라 로슈 아게 |
페녹시메틸 유도체
|
AR106135A1
(es)
|
2015-09-24 |
2017-12-13 |
Ionis Pharmaceuticals Inc |
Moduladores de la expresión del sarcoma de la rata de kirsten (kras)
|
CA2983782A1
(en)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
Bicyclic compounds as atx inhibitors
|
WO2017050791A1
(en)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
New bicyclic compounds as dual atx/ca inhibitors
|
CA2984585A1
(en)
|
2015-09-24 |
2017-03-30 |
F. Hoffmann-La Roche Ag |
New bicyclic compounds as dual atx/ca inhibitors
|
CN107922412B
(zh)
|
2015-09-24 |
2021-02-23 |
豪夫迈·罗氏有限公司 |
作为atx抑制剂的二环化合物
|
US10323038B2
(en)
|
2015-11-20 |
2019-06-18 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
WO2017087858A1
(en)
|
2015-11-20 |
2017-05-26 |
Abide Therapeutics, Inc. |
Pyrazole compounds and methods of making and using same
|
BR112018009798A8
(pt)
|
2015-11-25 |
2019-02-26 |
Dana Farber Cancer Inst Inc |
inibidores de bromodomínio bivalentes e usos dos mesmos
|
AU2016362040B2
(en)
|
2015-12-01 |
2019-10-10 |
Nihon Nohyaku Co., Ltd. |
3H-pyrrolopyridine compound, N-oxide thereof or salt thereof, agricultural and horticultural insecticide comprising the compound and method for using the same
|
WO2017139978A1
(zh)
|
2016-02-19 |
2017-08-24 |
吴伟东 |
手机app更新方法及系统
|
CR20190423A
(es)
|
2017-03-16 |
2019-11-01 |
Hoffmann La Roche |
Nuevos compuestos biciclícos como inhibidores dobles de atx/ca
|
JP7090099B2
(ja)
|
2017-03-16 |
2022-06-23 |
エフ.ホフマン-ラ ロシュ アーゲー |
Atxインヒビターとしての新規二環式化合物
|
NZ748072A
(en)
|
2017-03-20 |
2020-06-26 |
Forma Therapeutics Inc |
Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
|